Best Life Sciences & BioTech Brands 2026

Physics-based molecular simulation platform used by 1,700+ organizations. Q3 2025 software revenue u

ConcertAI is an oncology AI and real-world data company at a $1.9B valuation — 5.5M multi-modal canc

Pioneer of implantable BCIs with 12+ active human patients as of Sep 2025; raised $650M Series E in

DNAnexus is the leading precision health data cloud, managing 65+ petabytes of biomedical data for 1

World's dominant DNA sequencing platform with ~80% market share; ~$4.34B FY2025 revenue. Powers clin

Florence Healthcare is the leading clinical trial site enablement platform, connecting 12,000+ resea

Leading single-cell genomics platform; $642M FY2025 revenue. Chromium and Visium spatial platforms p

Pioneering organ-on-chip platform installed in 150+ labs including 17 of the top 25 biopharma compan

Tarrytown NY biopharma giant; creator of Dupixent (>$14B revenue), Eylea, and Kevzara. Velocity Geno

Saluda Medical is the pioneer of closed-loop spinal cord stimulation (SCS); FDA-approved Evoke SCS s

Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B

Karius raised $409M total including a $100M Series C in May 2024; its genomic blood test detects 1,0

Dotmatics (acquired by Insightful Science 2024) serves 1M+ researchers at 10,000+ organizations; R&D

IPO Nov 2025 (BLLN, Nasdaq); $273M raised; 508K+ tests in 2025; $293–299M revenue guidance FY2025.

Saama Analytics is the #1 AI clinical analytics platform for life sciences; received up to $430M Car

Opentrons democratizes lab automation with 10,000+ OT-2 and Flex robotic systems deployed globally;

Roche subsidiary and founding biotech; invented the biologics industry with recombinant DNA. Blockbu

German mRNA pioneer co-developed COVID-19 vaccine with Pfizer; 20+ clinical programs in oncology and

MasterControl is the leading QMS and MES platform for regulated life sciences industries, serving 1,

AI protein design platform combining language models with lab automation; active learning cycles for

Insilico Medicine (HKEX: 3696) raised $293M, posted $56.2M revenue in 2025, and inked a $2.75B Eli L

Mammoth Biosciences is a CRISPR gene editing company co-founded by Nobel laureate Jennifer Doudna; p

Axtria delivers AI-powered analytics and commercial software to 16 of the top 20 global life science

UK nanopore sequencing pioneer with portable MinION device; £223M FY2025 revenue (+24% constant curr

Delfi Diagnostics has raised $332M total to develop blood-based cancer detection using whole-genome

Nuvig Therapeutics develops first-in-class Fc-fragment immunomodulators targeting endogenous regulat

Reify Health raised $220M Series D at $4.8B valuation; OneStudyTeam and Care Access accelerate clini

NextPoint Therapeutics is a clinical-stage immuno-oncology company targeting the HHLA2 checkpoint wi

Vial is a tech-enabled CRO that converts dermatology and ophthalmology clinics into research sites,

Raised $250M Series B (Jan 2026). $650M+ total raised. Mirador360 genetics-first platform. 10+ clini

ChromaCode develops HDPCR technology enabling standard PCR instruments to run highly multiplexed mol

CAP- and CLIA-accredited clinical genetic testing lab offering cancer risk, cardiac, pharmacogenomic

Truvian Health received FDA 510(k) clearance for its TruVerus benchtop blood analyzer in Dec 2025; r

GATC Health uses its Multiomics Advanced Technology (MAT) platform to simulate human biochemistry an

ROME Therapeutics pioneers drugs targeting the dark genome — genomic repeats implicated in cancer an

Elligo Health Research brings clinical trials into healthcare settings by using EHR data for patient

Emerald Cloud Lab offers a fully remote, cloud-controlled laboratory with 200+ instrument models; ~$

Vancouver-based antibody discovery platform with 104+ partner programs; $75M FY2025 revenue. Expandi

SHINE Technologies uses fusion neutron technology to produce medical isotopes; received a conditiona

Caidya is a global mid-sized CRO formed from the merger of dMed Global and Clinipace; operates in 20

Synchron pioneers the world's first endovascular BCI (Stentrode) enabling paralysis patients to cont

BostonGene is an AI-powered precision oncology company using multiomics and tumor microenvironment a

Raised $381M IPO on Nasdaq (Feb 2026, EIKN). Proprietary RESOLFT super-resolution microscopy tracks

Nasdaq-listed (PRME). $191M cash runway into 2027. IND for Wilson's Disease H1 2026. AATD IND mid-20

Synthekine engineers selective cytokine therapeutics for cancer and autoimmune disease; $289M raised

Phlow raised $37M Series C in July 2025 and holds $600M+ in government contracts including a $354M B

Detect pioneered the FDA-authorized rapid at-home molecular COVID-19 test and is now developing a se

Clasp Therapeutics develops tumor-specific T cell engagers targeting mutant p53 and other cancer dri

Formation Bio is an AI-native pharmaceutical company that acquires clinical-stage drug assets and ac

Absci is an AI drug creation company that combines generative AI with a synthetic biology platform t